National Institute of Allergy and Infectious Disease

‘US’ HDT Bio begins Phase-III trial of COVID-19 vaccine in India

Washington: US-based biopharmaceutical company HDT Bio Corp on Wednesday announced to begin Phase III trial of its COVID-19 vaccine in India. The Phase III trial of the vaccine developed by HDT Bio in partnership with Gennova Biopharmaceuticals in India is expected to be an affordable one as compared to the existing vaccines in the west. ”This trial is a major milestone […]